Lykos Therapeutics (formerly MAPS PBC)
Wael Garas is a hospitalist with extensive experience in various medical roles. Currently serving as a hospitalist since April 2023, Wael has also worked as a researcher at MAPS Public Benefit Corporation since 2019, contributing as a co-principal investigator and study physician for Phase 2 and 3 trials involving MDMA for PTSD. Previous roles include primary care physician and hospitalist at Boulder Community Health from 2015 to October 2022, medical director of integrative medicine at SCL Health from 2011 to 2014, and hospitalist at Sound Physicians from 2007 to 2011. Wael's educational background includes an integrative medicine fellowship at the University of Arizona College of Medicine, an internal medicine residency at the University of Nevada School of Medicine, and a Doctor of Medicine degree from The Ohio State University College of Medicine.